PEOPLE

He has a multi-disciplinary background in science, engineering and strategy, and with a strong research interest in the 'social license to operate' for research infrastructure.

to Australia’s research communities in biomedicine, environmental and agricultural science.

at the Institute of Higher Education of Brasília (IESB), where she currently serves as a member of the Institutional Evaluation Committee representing the external community.
Since 2011, she has been a Science and Technology Analyst at the National Council for Scientific and Technological Development (CNPq), having held the positions of Deputy Coordinator for International Actions and Management of International Programmes and Coordinator for Information and International Studies.

She currently serves as Coordinator for Negotiation, Advisory and International Studies and Deputy General Coordinator of the General Coordination for International Cooperation in Science, Technology and Innovation (STI) at CNPq.

for Research Infrastructures, contributes to the national strategy on technology infrastructures and represents France in international bodies.

Between 2020 and 2025, Ewan held key leadership roles at EMBL. He has been Director of EMBL-EBI since 2015 and was Associate Director from 2012 to 2015. Before that, he was the Head of Nucleotide Data at EMBL-EBI (2000-2015).

Ewan led the analysis of the Human Genome gene set, mouse and chicken genomes and the ENCODE project, focusing on non-coding elements of the human genome. His main areas of research include functional genomics, DNA algorithms, statistical methods to analyse genomic information, and use of images for chromatin structure.

A non-executive Director of Genomics England and the UK’s Health Data Research Service, Ewan is also a consultant and advisor to a number of companies, including Oxford Nanopore Technologies and Cantata Bio.

He was elected an EMBO member in 2012, a Fellow of the Royal Society in 2014, and a Fellow of the Academy of Medical Sciences in 2015. Ewan was appointed Commander of the Order of the British Empire (CBE) in 2019. He was also elected as a member of The Royal Danish Academy of Sciences and Letters in 2024.

In 2019, Ewan became a Board Member of the Biotechnology and Biological Sciences Research Council (BBSRC). Ewan serves on a number of Scientific Advisory Boards, including for the Wellcome Genome Campus, DKFZ, the Institute of Cancer Research (ICR), Institute Pasteur, Riken Institute, Molecular Infection Medicine Sweden (MIMS), the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), and the Research Center for Molecular Medicine (CeMM) in Vienna.

He has received a number of awards, including the 2003 Francis Crick Award from the Royal Society, the 2005 Overton Prize from the International Society for Computational Biology, and the 2005 Benjamin Franklin Award for contributions in Open Source Bioinformatics.

Ewan completed his PhD at the Wellcome Sanger Institute with Richard Durbin. He holds honorary doctorates from the University of Tartu in Estonia and Birkbeck College at the University of London, UK.

The current GSF portfolio includes work on core facilities, international research infrastructures, the role and impact of curiosity-driven research, research security issues and on the research workforce. Frédéric Sgard acts as independent expert for various European research infrastructure projects. Prior joining the OECD, he worked as senior scientist in a pharmaceutical company until the end of 2002, on the discovery of new pharmacological targets. Trained as a molecular biologist, he studied Molecular Genetics at the University of Paris-Saclay (France), and obtained his Ph.D. from the University of Reading, UK, in 1994.

in collaboration with CNR and Elettra in Trieste, Italy. He coordinates the NFFA-Europe (Nano Foundries and Fine Analysis – www.NFFA.eu) European research infrastructure for nanoscience since 2008. He has chaired the ESFRI Physical Sciences and Engineering Strategy Work group in 2013-2016 and served as ESFRI Chair in 2016-2018.

GR has chaired in 2019 the High-Level Expert Group on Long Term Sustainability of Research Infrastructure. He has coordinated the expert group who wrote the Italian National Plan for Open Science that become effective in 2022.

He represents Italy in the EOSC Steering Board and contributes as co-chair to the Policy sub-group. GR is the Italian Senior Official of the GSO on global research infrastructures, Chair of GSO in 2026. He is author or co-author of over 270 research papers in ISI journals, H=43.

including MINISAT, XMM-Newton, and the James Webb Space Telescope's MIRI instrument. Since joining Spain's Ministry of Science, Innovation and Universities in 2009, she has coordinated Spain's participation in major international research infrastructures, representing the country in the governing bodies of CERN, ESO, EMBL, F4E, SKAO (currently Vice-Chair), IFMIF-DONES, ET, LifeWatch, EBRAINS, among others. She served on ESFRI's Executive Board (2016-2024), including as Vice-Chair (2018–2024).

She has also driven EU-Latin America and Caribbean research cooperation, coordinating EU-LAC ResInfra and its successor, EU-LAC ResInfra Plus projects, and serves as Spain's delegate to CYTED Programme.

and is the scientific guarantor for the Czech Roadmap of large research infrastructures. Previously, he managed European Science Policy affairs at Czech Academy of Sciences and before he got appointed Director General for Research at the Ministry of Education, Youth, and Sports of the Czech Republic.

With extensive experience in science policy, evaluation, and management, Jan has been a long-standing member of the European Strategy Forum for Research Infrastructures (ESFRI), serving as Chair from 2019 to 2021, and he still actively contributing to ESFRI as an executive board member.

Presently, he also is the Czech delegate to the European Research and Innovation Area Committee (ERAC) - a position he has held since 2010 - as well as a member of the Global Science Forum of the OECD. He is actively involved in implementing Open Science policies at both the EU and national levels. He has served on the EOSC executive board and currently represents the Czech Republic on the EOSC Steering Board. Additionally, he is a member of the Czech National EOSC Coordination Council and provides guidance on EOSC-related national developments.

at Brookhaven National Laboratory in the USA. He was Full Professor of Physics at the University of Madrid (1984–1987) and later worked at the European research facility Institut Laue Langevin in Grenoble, France.

In 1992, he joined the CSIC at the Institute of Materials Science in Madrid (ICMM) and held several senior research management roles, including Deputy Director General for Research Projects at the Spanish State Secretariat for R&D and Deputy Director General of Institut Laue Langevin (2007–2012).

Since 2016, he has served on the French Nuclear Waste Evaluation Commission and is Chair of the European Strategy Forum for Research Infrastructures (ESFRI) for the period 2024-2026. He holds a PhD in Materials Physics from the Universidad Autónoma de Madrid.

She is an atmospheric chemist specializing in the measurement of traces gases and was previously a full professor of atmospheric sciences at the University of Colorado Boulder.

that advises the Australian Commonwealth Department of Education on research infrastructure planning.

In 2013 she was appointed BBMRI.it Node-Director. In December 2020 she was elected - confirmed in 2024 - in the board of directors of the EOSC Association and serves as vice-president. Prof. Lavitrano has a long-term experience in research, management, training and in bioethical aspects of science, with leading roles in 17 European funded projects within H2020 and Horizon programs, 14 of which related to research infrastructures.

as well as having responsibility for a diverse portfolio of awards. He was founding chair for the creation of the organisation’s internal Equality, Diversity and Inclusion (EDI) strategy and action plan.

Michael has served on several international review panels and European Commission Expert Groups including the Expert Group on Technology Infrastructures, representing the ESFRI. He is a Board member to the European Strategy Forum on Research Infrastructures and on the Advisory Board to the European Commission R&I Partnership platform, ERA-LEARN.

Prior to this Michael worked in the private sector, which included partnering with global corporations in the US and Asia. His experience spans across a variety of activities that include global partnership creation, advising on policy development for government, scaleup of translational research facilities, and raising venture capital funds. Michael holds a PhD in Physical and Analytical Chemistry from University College Dublin.

With more than 26 years of experience spanning academia, government and funding organizations, he now operates at the intersection of science, policy and leadership. He actively influences and advances the CFI’s mandate, guiding the evolution of Canada’s research and innovation ecosystem, while also driving measurable economic and societal impact to make that ecosystem a strong and sustainable one.

Internationally, he represents Canada as an ad hoc expert to the European Strategy Forum on Research Infrastructures, including its Strategy Working Group on Environment, where he contributes to advancing global collaboration and sustainability priorities in research infrastructure.

Throughout his career, Mohamad Nasser-Eddine has led transformative initiatives to enhance the impact of large-scale research investments, promote inclusive access to cutting-edge facilities, and advance responsible approaches to research assessment. He is particularly committed to fostering the next generation of talent, emphasizing the development of “T-shaped” skills that combine deep expertise with interdisciplinary capacity.

He holds a PhD in chemistry and an executive MBA in technology management and began his career as a research scientist specializing in drug delivery systems.

100+ papers, 40000+ citations and multiple awards. He led the CNR Institute of Materials and offers extensive board experience shaping national and EU-level innovation policies: EuroHPC JU Governing Board, European XFEL Council, ChipsJU WBG pilot line.

in managing research reactor and accelerator facilities. Specializing in neutron beam instrumentation, neutron scattering techniques, and related experimental methods, Dr. Park has made significant contributions to advancing materials research and international neutron science collaborations. His work supports the development of cutting-edge research infrastructures across Asia and globally.

Ministry of Education, Culture, Sports, Science and Technology (MEXT). He works on research infrastructure policy, AI-enabled research ecosystems.

Her education background is Ph.D. in Pharmaceutical Sciences (Advanced Drug delivery) from University of Nottingham, UK, in 2002. During 2002-2003, she was a post-doctoral research fellow at School of Biomedical Sciences, Queen’s Medical center, University of Nottingham working on Biomaterial research. Dr. Ruktanonchai took a researcher position at the National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Thailand in 2004.

Her research expertise is on encapsulation technology to control release and target bioactive compounds intended to be used for medical applications. Her research interest is in lipid dispersion, biocompatible polymeric nanoparticles and functionalized nanoparticles for Advance drug delivery system.

Dr. Ruktanonchai has published research findings for more than 152 international publications as well as filed more than 70 intellectual property. She also serves as advisors, invited speakers and guest lecturers for various universities and conferences domestically and internationally. She was awarded a “2010 Young Scientist” from the Foundation for the Promotion of Science and Technology under the Patronage of His Majesty the King, “2011 Women in Science” fellowship from UNESCO-L’Oreal Thailand.

She was selected as one of “66 Young Leaders Shaping Thailand’s Future of 2012” by the Bangkok Post which celebrated its 66 years in operation. In addition, she won UK alumni Award for Professional Achievement from the British council and UK Embassy in 2018 and has been listed as top 2% of the most cited scientist in the field of Pharmacy & Pharmacology since 2020. She has been appointed as Honorary Professor by University of Queensland, Australia, since 2017.